Jay Bombara - Profile and Investment Details

Investor Profile

Jay Bombara is a Venture Debt, Venture Capital, Private Equity Firm based in Farmington, Connecticut, United States with a diverse investment portfolio that includes companies such as CSA Medical, Aerin Medical, Titan Pharmaceuticals, GenePeeks, Bridge2 Solutions, New Haven Pharmaceuticals, IntelePeer, Alula Holdings, PebblePost, OutboundEngine, SpringCM, ScoreBig, Getaround, IntegenX, SilkRoad Technology, Nomi, Intarcia Therapeutics, Conventus Orthopaedics, Mederi Therapeutics, Audacy, Copan Systems, ZetrOZ, Mustang Bio, Ambit Biosciences, Mblox, SavingStar, Ontrak, Medsphere Systems, Castle Creek Biosciences, MacuLogix, Avalanche Technology, Interleukin Genetics, NinePoint Medical, New Signature, IgnitionOne, Meditrina, Inc, Corinth MedTech, Ceribell, Digital Signal, Palatin Technologies, Canary Medical, InVisage Technologies, Grab Media, Topia, Radisphere Radiology, Social Intelligence, Valore, Overture Networks, Argos Therapeutics, Encore Dermatology, Receptiv, AccuVein. Over time, Jay Bombara has demonstrated experience in supporting a range of businesses across various sectors.

While it is not publicly confirmed whether Jay Bombara is currently seeking new investment opportunities, their past investments provide valuable insight into the types of projects and industries that have attracted their attention.

Startups and entrepreneurs operating in sectors related to Advertising, Health Care, Marketing Automation, Smart Home, Women Founded, Medical Testing, Enterprise Software, HR Tech, Transportation, Android, Women Led, Car Sharing, Life Science, Product Design, Marketplace, Email Marketing, Collaborative Consumption, Mobile, Medical Device, Software, Healthcare, Biotechnology, Big Data Analytics, Clinical Trials, Employee Benefits, PeertoPeer, Financial Services, Social Media, Health Diagnostics, Medical, SaaS, Media and Entertainment, Pharmaceuticals, Biopharma, Security may find it worthwhile to explore potential connections with Jay Bombara, as their portfolio suggests a familiarity and interest in this area.

Understanding Jay Bombara’s investment history can offer useful context for founders considering outreach and help identify whether there is a potential fit based on strategic alignment and market focus.